Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pre-operative Tumor Treating Fields in Patients With Resectable Lung Cancer

NCT: NCT06552000 · WITHDRAWN

NCT IDNCT06552000
StatusWITHDRAWN
Start Date2026-10-01
Completion2030-12-01
SponsorUniversity of Texas Southwestern Medical Center (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to study the clinical and biologic effects of Tumor Treatment Fields (TTFields) in patients undergoing resection of stage I-IIIA Non-Small Cell Lung Cancer (NSCLC). TTField is a non-invasive treatment that uses low-intensity electrical fields to treat cancer. Resection is the medical term for surgically removing part or all of a tissue, structure, or organ.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑